|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||248.29 - 248.29|
|52-week range||248.29 - 248.29|
|Beta (5Y monthly)||1.45|
|PE ratio (TTM)||118.24|
|Earnings date||27 Jul 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
IQVIA's (IQV) second-quarter 2021 earnings and revenues are expected to have improved year over year.
RESEARCH TRIANGLE PARK, N.C., July 22, 2021--Digital health tools are increasingly having a positive impact on health outcomes. Some are becoming integral parts of mainstream medicine, according to findings released today by the IQVIA Institute for Human Data Science in a new report, Digital Health Trends 2021: Innovation, Evidence, Regulation, and Adoption.
Zacks Industry Outlook Highlights: IQVIA Holdings, Seagate Technology and Blucora